mafosfamide has been researched along with amifostine anhydrous in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Bouchet, S; Capizzi, RL; Conlon, J; Douay, L; Giarratana, MC; Gorin, NC; Hu, C | 1 |
| Bony, V; Jiang, R; Lopez, M | 1 |
| Gorin, NC | 1 |
| Bialleck, H; Fauth, F; Hoelzer, D; Martin, H; Mihanovic, B; Sonnhoff, S; Wiesneth, M | 1 |
1 review(s) available for mafosfamide and amifostine anhydrous
| Article | Year |
|---|---|
The potential role of amifostine (Ethyol) in haematological malignancies.
Topics: Acute Disease; Adult; Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1996 |
1 trial(s) available for mafosfamide and amifostine anhydrous
| Article | Year |
|---|---|
Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
Topics: Acute Disease; Adjuvants, Immunologic; Adult; Amifostine; Bone Marrow; Bone Marrow Purging; Cyclophosphamide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Leukemia; Male; Middle Aged; Stem Cells; Transplantation, Autologous | 2000 |
3 other study(ies) available for mafosfamide and amifostine anhydrous
| Article | Year |
|---|---|
Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow Purging; Bone Marrow Transplantation; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells | 1995 |
Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
Topics: Amifostine; Antineoplastic Agents; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Cell Death; Cyclophosphamide; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Autologous | 1995 |
Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Topics: Amifostine; Animals; Bone Marrow Purging; Bone Marrow Transplantation; Colony-Forming Units Assay; Cyclophosphamide; Hematopoietic Stem Cells; In Vitro Techniques; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Transplantation, Autologous | 1994 |